Clinical Breakthroughs and Market Evolution in Lung Cancer

Sam Fazeli

Head of EMEA Research

Bloomberg

Sam Fazeli is a senior analyst and the EMEA head of Bloomberg Intelligence, a dynamic platform for in-depth research available on the Bloomberg Professional service at BI . Dr. Fazeli specializes in global pharmaceuticals, bringing over 20 years of experience conducting equity research as a pharmaceutical analyst, working at firms such as Nomura International and HSBC. Prior to joining Bloomberg in 2010, Dr. Fazeli worked at Piper Jaffray, Ltd. as a pharmaceutical analyst and head of European research. Before transitioning to investment banking, he was a research scientist for seven years. Dr. Fazeli has been ranked a top analyst by both the U.K. and Pan-European Extel surveys. He received a bachelor’s of science from Cardiff University, and a Ph.D. in pharmacology from the University of London.

Tish Walker

Senior Research Analyst

Bloomberg Intelligence

Letitia (Tish) Walker is a Senior Litigation Analyst on the healthcare team at Bloomberg Intelligence. Prior to Bloomberg, Tish was a Director in the intellectual property group at Merck & Co, Inc. where she was responsible patent procurement, freedom to operate analysis, and due diligence for large molecule products and pipeline programs. Before joining Merck, she was a Partner at Akerman LLP, where her practice primarily focused on patent opinion work for companies seeking to enter the market with a biosimilar or generic product. Tish began her law career at a boutique firm in NYC where her focus was on drafting and procuring life science related patents in various regions. Tish holds a law degree from Brooklyn Law School, a Master’s in Biology from New York University, and a Bachelor’s degree in Chemistry from The George Washington University.